In a breast cancer mouse model, conteltinib was found to inhibit tumor growth and spontaneous metastasis to the lung (Liu P et al., 2022), with the inhibitory effect on tumor invasion and metastasis primarily attributed to FAK inhibition. This evidence concerns the gene PTK2 and neoplasm.